Beisi Biology
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $15M
Investors
- 10
About Beisi Biology
Established in 2021 and based in Shanghai, China, Beisi Biology operates as a biotechnology company dedicated to providing NK cell tumour treatment and gene editing technologies. It has a sub-branch office in America. The founding team most from Stanford University School of Medicine, Baylor College of Medicine and MD Anderson Cancer Center. The company has obtained 29 intellectual property applications, covering software copyright, utility model patents, national invention patents, PCT and US patents. The company provides NK cell tumour treatment and gene editing technologies and related products. It has developed nearly 200 base editing tools. Its pipeline includes NK cells, super-NK, super-ipsc NK(iNK) and in vivo. And products can apply in biologics, agriculture and new tools fields, and be achieved zero off-target. The product is suitable for a variety of solid tumours including lung cancer, liver cancer, brain glioma, etc. The company generates revenue by providing NK cell tumour treatment, gene editing technologies, and related products.
Who invested in Beisi Biology
10 investors across 3 rounds
See all investors in Beisi Biology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beisi Biology
Who invested in Beisi Biology?
Beisi Biology has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beisi Biology raised?
Beisi Biology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beisi Biology last raise money?
Beisi Biology's most recent round on record is a Series A, in Sep 2024.
What does Beisi Biology do?
Established in 2021 and based in Shanghai, China, Beisi Biology operates as a biotechnology company dedicated to providing NK cell tumour treatment and gene editing technologies.
Where is Beisi Biology headquartered?
Beisi Biology is headquartered in Shanghai, China.
Which VCs invest in companies like Beisi Biology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beisi Biology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beisi Biology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.